Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Use of hydroxyethyl starch in sepsis research: Protocol for a systematic review.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370270 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-6576 (Electronic) Linking ISSN: 00015172 NLM ISO Abbreviation: Acta Anaesthesiol Scand Subsets: MEDLINE
    • Publication Information:
      Publication: Oxford, UK : Wiley-Blackwell
      Original Publication: Aarhus, Denmark : Universitetsforlaget, 1957-
    • Subject Terms:
      Fluid Therapy/*adverse effects ; Hydroxyethyl Starch Derivatives/*adverse effects ; Sepsis/*therapy; Animals ; Clinical Protocols ; Humans
    • Abstract:
      Introduction: Hydroxyethyl starch (HES) 130/0.38-0.45 is a synthetic colloid, which has been on the market since 1999. In recent years, concern about the use of HES has been raised because of serious adverse events, including acute kidney injury, bleeding and even increased mortality with its use. In the outlined systematic review, we aim to assess if the adverse effects of HES 130/0.38-0.45 in patients with sepsis could have been discovered earlier.
      Methods: We will conduct a systematic review with meta-analysis of randomised clinical trials in animals and patients and observational studies in patients comparing HES 130/0.38-0.45 vs any crystalloid in sepsis. The primary outcome will be all-cause mortality at longest follow-up. We will systematically search EMBASE, MEDLINE and the Cochrane Library for relevant literature. We will follow the recommendations by the Cochrane Handbook, the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statements and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.
      Discussion: With the outlined systematic review, we aim to assess whether the adverse effects of HES 130/0.38-0.45 could have been discovered earlier by comparing summary effect estimates of harm from observational studies in patients and randomised trials in animals and patients. The results may have implications for future drug development and approval processes.
      (© 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.)
    • Contributed Indexing:
      Keywords: adverse effects; hydroxyethyl starch (HES) 130/0.38-0.45; sepsis
    • Accession Number:
      0 (Hydroxyethyl Starch Derivatives)
    • Publication Date:
      Date Created: 20190319 Date Completed: 20200831 Latest Revision: 20200831
    • Publication Date:
      20231215
    • Accession Number:
      10.1111/aas.13345
    • Accession Number:
      30882897